Important differences between human and mouse APOE gene promoters: Limitation of mouse APOE model in studying Alzheimer's disease

Bryan Maloney, Yuan Wen Ge, George M. Alley, Debomoy Lahiri

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Apolipoprotein E (ApoE), encoded by the apolipoprotein E gene (APOE), plays an important role in the pathogenesis of Alzheimer's disease (AD). The APOE ε4 variant is strongly associated with AD. APOE promoter polymorphisms have also been reported to associate with higher AD risk. Mouse models of APOE expression have long been used to study the pathogenesis of AD. Elucidating the role of the APOE gene in AD requires understanding of how its regulation differs between mouse and human APOE genes, and how the differences influence AD risk. We compared the structure and function of both the human APOE gene promoter (hAPOEP) and mouse APOE gene promoter (mAPOEP) regions. Homology is less than 40% at 180 bp or more upstream of the two species' transcription start site (TSS, +1). Functional analysis revealed both similarities and important differences between the two sequences, significantly affected by human versus rodent cell line origin. We likewise probed nuclear extracts from several cell lines of different origins (astrocytic, glial, and neuronal) and mouse brain with specific hAPOEP and mAPOEP fragments. Each fragment shared DNA-protein interactions with the other but, notably, also bound distinct factors, demonstrated by gel shift and southwestern analyses. We determined possible identities for these distinct factors. These results suggest that regulation of mouse and human APOE genes may be sufficiently unique to justify the use of both the human APOE promoter sequence in transgenic rodent models and non-rodent AD models for studying factors involved in AD pathogenesis.

Original languageEnglish
Pages (from-to)1237-1257
Number of pages21
JournalJournal of Neurochemistry
Volume103
Issue number3
DOIs
StatePublished - Nov 2007

Fingerprint

Apolipoproteins E
Alzheimer Disease
Genes
Rodentia
Cells
Apolipoprotein E4
Cell Line
Functional analysis
Transcription Initiation Site
Electrophoretic Mobility Shift Assay
Polymorphism
Genetic Promoter Regions
Gene expression
Neuroglia

Keywords

  • Aging
  • Amyloid
  • Brain
  • Cholesterol
  • Gene regulation
  • Glia
  • Lipid
  • Neuron
  • Nuclear factor
  • Promoter
  • Transcription

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Important differences between human and mouse APOE gene promoters : Limitation of mouse APOE model in studying Alzheimer's disease. / Maloney, Bryan; Ge, Yuan Wen; Alley, George M.; Lahiri, Debomoy.

In: Journal of Neurochemistry, Vol. 103, No. 3, 11.2007, p. 1237-1257.

Research output: Contribution to journalArticle

@article{a999dddfe6b14b9193934683baa1c413,
title = "Important differences between human and mouse APOE gene promoters: Limitation of mouse APOE model in studying Alzheimer's disease",
abstract = "Apolipoprotein E (ApoE), encoded by the apolipoprotein E gene (APOE), plays an important role in the pathogenesis of Alzheimer's disease (AD). The APOE ε4 variant is strongly associated with AD. APOE promoter polymorphisms have also been reported to associate with higher AD risk. Mouse models of APOE expression have long been used to study the pathogenesis of AD. Elucidating the role of the APOE gene in AD requires understanding of how its regulation differs between mouse and human APOE genes, and how the differences influence AD risk. We compared the structure and function of both the human APOE gene promoter (hAPOEP) and mouse APOE gene promoter (mAPOEP) regions. Homology is less than 40{\%} at 180 bp or more upstream of the two species' transcription start site (TSS, +1). Functional analysis revealed both similarities and important differences between the two sequences, significantly affected by human versus rodent cell line origin. We likewise probed nuclear extracts from several cell lines of different origins (astrocytic, glial, and neuronal) and mouse brain with specific hAPOEP and mAPOEP fragments. Each fragment shared DNA-protein interactions with the other but, notably, also bound distinct factors, demonstrated by gel shift and southwestern analyses. We determined possible identities for these distinct factors. These results suggest that regulation of mouse and human APOE genes may be sufficiently unique to justify the use of both the human APOE promoter sequence in transgenic rodent models and non-rodent AD models for studying factors involved in AD pathogenesis.",
keywords = "Aging, Amyloid, Brain, Cholesterol, Gene regulation, Glia, Lipid, Neuron, Nuclear factor, Promoter, Transcription",
author = "Bryan Maloney and Ge, {Yuan Wen} and Alley, {George M.} and Debomoy Lahiri",
year = "2007",
month = "11",
doi = "10.1111/j.1471-4159.2007.04831.x",
language = "English",
volume = "103",
pages = "1237--1257",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Important differences between human and mouse APOE gene promoters

T2 - Limitation of mouse APOE model in studying Alzheimer's disease

AU - Maloney, Bryan

AU - Ge, Yuan Wen

AU - Alley, George M.

AU - Lahiri, Debomoy

PY - 2007/11

Y1 - 2007/11

N2 - Apolipoprotein E (ApoE), encoded by the apolipoprotein E gene (APOE), plays an important role in the pathogenesis of Alzheimer's disease (AD). The APOE ε4 variant is strongly associated with AD. APOE promoter polymorphisms have also been reported to associate with higher AD risk. Mouse models of APOE expression have long been used to study the pathogenesis of AD. Elucidating the role of the APOE gene in AD requires understanding of how its regulation differs between mouse and human APOE genes, and how the differences influence AD risk. We compared the structure and function of both the human APOE gene promoter (hAPOEP) and mouse APOE gene promoter (mAPOEP) regions. Homology is less than 40% at 180 bp or more upstream of the two species' transcription start site (TSS, +1). Functional analysis revealed both similarities and important differences between the two sequences, significantly affected by human versus rodent cell line origin. We likewise probed nuclear extracts from several cell lines of different origins (astrocytic, glial, and neuronal) and mouse brain with specific hAPOEP and mAPOEP fragments. Each fragment shared DNA-protein interactions with the other but, notably, also bound distinct factors, demonstrated by gel shift and southwestern analyses. We determined possible identities for these distinct factors. These results suggest that regulation of mouse and human APOE genes may be sufficiently unique to justify the use of both the human APOE promoter sequence in transgenic rodent models and non-rodent AD models for studying factors involved in AD pathogenesis.

AB - Apolipoprotein E (ApoE), encoded by the apolipoprotein E gene (APOE), plays an important role in the pathogenesis of Alzheimer's disease (AD). The APOE ε4 variant is strongly associated with AD. APOE promoter polymorphisms have also been reported to associate with higher AD risk. Mouse models of APOE expression have long been used to study the pathogenesis of AD. Elucidating the role of the APOE gene in AD requires understanding of how its regulation differs between mouse and human APOE genes, and how the differences influence AD risk. We compared the structure and function of both the human APOE gene promoter (hAPOEP) and mouse APOE gene promoter (mAPOEP) regions. Homology is less than 40% at 180 bp or more upstream of the two species' transcription start site (TSS, +1). Functional analysis revealed both similarities and important differences between the two sequences, significantly affected by human versus rodent cell line origin. We likewise probed nuclear extracts from several cell lines of different origins (astrocytic, glial, and neuronal) and mouse brain with specific hAPOEP and mAPOEP fragments. Each fragment shared DNA-protein interactions with the other but, notably, also bound distinct factors, demonstrated by gel shift and southwestern analyses. We determined possible identities for these distinct factors. These results suggest that regulation of mouse and human APOE genes may be sufficiently unique to justify the use of both the human APOE promoter sequence in transgenic rodent models and non-rodent AD models for studying factors involved in AD pathogenesis.

KW - Aging

KW - Amyloid

KW - Brain

KW - Cholesterol

KW - Gene regulation

KW - Glia

KW - Lipid

KW - Neuron

KW - Nuclear factor

KW - Promoter

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=35248846473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35248846473&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2007.04831.x

DO - 10.1111/j.1471-4159.2007.04831.x

M3 - Article

C2 - 17854398

AN - SCOPUS:35248846473

VL - 103

SP - 1237

EP - 1257

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -